Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Stellate Ganglion Morphine Infiltration for Reperfusion Injury in STEMI
NCT07023679Recruiting
- Sponsor
- The Second Affiliated Hospital of Anhui Medical University
- Start
- Jun 2025
- Primary completion
- Jun 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of morphine in ST elevation myocardial infarction (STEMI), sponsored by The Second Affiliated Hospital of Anhui Medical University. Primary endpoint: Major Adverse Cardiovascular and Cerebrovascular Events at 1 year. Started Jun 2025; status: recruiting.
02
Drugs
morphine
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT07023679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07023679.